Michael Thomas Heffernan - Net Worth and Insider Trading

Over the past 18 months, Michael Thomas Heffernan made 3 insider transaction in Collegium Pharmaceutical Inc (COLL) with a net sale of 298,612. Other recent insider transactions involving Collegium Pharmaceutical Inc (COLL) include a net sale of 153,453 shares made by Joseph Ciaffoni , a net sale of 34,086 shares made by Scott Dreyer , and a net sale of 38,889 shares made by Shirley R. Kuhlmann .

In summary, during the past 3 months, insiders sold 469,899 shares of Collegium Pharmaceutical Inc (COLL) in total and bought 0 shares, with a net sale of 469,899 shares. During the past 18 months, 529,390 shares of Collegium Pharmaceutical Inc (COLL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 529,390 shares.

Collegium Pharmaceutical Inc (COLL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Thomas Heffernan made no insider transaction in Trevi Therapeutics Inc (TRVI). Other recent insider transactions involving Trevi Therapeutics Inc (TRVI) include a net sale of 1,000,000 shares made by Tpg Gp A, Llc , a net purchase of 3,580,526 shares made by Florence Anthony A. Jr. , and a net purchase of 3,580,526 shares made by Ali Behbahani .

In summary, during the past 3 months, insiders sold 0 shares of Trevi Therapeutics Inc (TRVI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,000,000 shares of Trevi Therapeutics Inc (TRVI) were sold and 30,326,838 shares were bought by its insiders, resulting in a net purchase of 29,326,838 shares.

Trevi Therapeutics Inc (TRVI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Thomas Heffernan made no insider transaction in Akebia Therapeutics Inc (AKBA). Other recent insider transactions involving Akebia Therapeutics Inc (AKBA) include a net sale of 2,189 shares made by Steven Keith Burke , a net sale of 5,833 shares made by Violetta Cotreau , and a net sale of 4,567 shares made by Steven C Gilman .

In summary, during the past 3 months, insiders sold 0 shares of Akebia Therapeutics Inc (AKBA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 12,589 shares of Akebia Therapeutics Inc (AKBA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 12,589 shares.

Akebia Therapeutics Inc (AKBA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Thomas Heffernan made no insider transaction in Biohaven Pharmaceutical Holding Co Ltd (BHVN). Other recent insider transactions involving Biohaven Pharmaceutical Holding Co Ltd (BHVN) include a net sale of 15,490 shares made by George C. Clark , a net sale of 62,265 shares made by Declan Doogan , and a net purchase of 38,000 shares made by Gregory Bailey .

In summary, during the past 3 months, insiders sold 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 153,613 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) were sold and 43,000 shares were bought by its insiders, resulting in a net sale of 110,613 shares.

Biohaven Pharmaceutical Holding Co Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Keryx Biopharmaceuticals Inc (KERX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Keryx Biopharmaceuticals Inc (KERX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Keryx Biopharmaceuticals Inc (KERX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Ocata Therapeutics Inc (OCAT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocata Therapeutics Inc (OCAT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ocata Therapeutics Inc (OCAT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Thomas Heffernan made no insider transaction in Synlogic Inc (SYBX). Other recent insider transactions involving Synlogic Inc (SYBX) include a net purchase of 9,500 shares made by Michael Vangsted Jensen , a net sale of 8,894 shares made by Aoife Brennan , and a net sale of 2,650 shares made by Antoine Awad .

In summary, during the past 3 months, insiders sold 0 shares of Synlogic Inc (SYBX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,544 shares of Synlogic Inc (SYBX) were sold and 9,500 shares were bought by its insiders, resulting in a net sale of 2,044 shares.

Synlogic Inc (SYBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Thomas Heffernan made no insider transaction in Biohaven Ltd (BHVN). Other recent insider transactions involving Biohaven Ltd (BHVN) include a net purchase of 1,021,110 shares made by Vlad Coric , a net purchase of 3,900,000 shares made by John W Childs , and a net purchase of 200,000 shares made by Gregory Bailey .

In summary, during the past 3 months, insiders sold 0 shares of Biohaven Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biohaven Ltd (BHVN) were sold and 5,273,490 shares were bought by its insiders, resulting in a net purchase of 5,273,490 shares.

Biohaven Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.